NCT03562377 · Interventional trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Overall registry status Completed
Phase 2
Conditions Atopic Dermatitis
Delaware Valley sites
- Leo Pharma Investigational Site · East Windsor, NJ · Mercer County
First posted
Registry updated
Added to the directory